000			02148 a2200637 4500
005			20250517135833.0
264		0	_c20180321
008			201803s 0 0 eng d
022			_a1748-1716
024	7		_a10.1111/apha.12829 _2doi
040			_aNLM _beng _cNLM
100	1		_aOosterhuis, N R
245	0	0	_aTargeting multiple pathways reduces renal and cardiac fibrosis in rats with subtotal nephrectomy followed by coronary ligation. _h[electronic resource]
260			_bActa physiologica (Oxford, England) _c07 2017
300			_a382-393 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAngiotensin II Type 1 Receptor Blockers _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAntioxidants _xpharmacology
650	0	4	_aCardio-Renal Syndrome _xdrug therapy
650	0	4	_aCoronary Vessels
650	0	4	_aCyclic N-Oxides _xpharmacology
650	0	4	_aDisease Models, Animal
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFibrosis
650	0	4	_aHeart _xdrug effects
650	0	4	_aKidney _xdrug effects
650	0	4	_aKidney Function Tests
650	0	4	_aLigation
650	0	4	_aLosartan _xpharmacology
650	0	4	_aMale
650	0	4	_aMetoprolol _xpharmacology
650	0	4	_aMolsidomine _xpharmacology
650	0	4	_aNF-kappa B _xantagonists & inhibitors
650	0	4	_aNephrectomy
650	0	4	_aNitric Oxide Donors _xpharmacology
650	0	4	_aPyrrolidines _xpharmacology
650	0	4	_aRats, Inbred Lew
650	0	4	_aSpin Labels
650	0	4	_aSympatholytics _xpharmacology
650	0	4	_aThiocarbamates _xpharmacology
700	1		_aBongartz, L G
700	1		_aVerhaar, M C
700	1		_aCheng, C
700	1		_aXu, Y J
700	1		_avan Koppen, A
700	1		_aCramer, M J
700	1		_aGoldschmeding, R
700	1		_aGaillard, C A
700	1		_aDoevendans, P A
700	1		_aBraam, B
700	1		_aJoles, J A
773	0		_tActa physiologica (Oxford, England) _gvol. 220 _gno. 3 _gp. 382-393
856	4	0	_uhttps://doi.org/10.1111/apha.12829 _zAvailable from publisher's website
999			_c26857219 _d26857219